Where is Chimerix headquartered?

Chimerix is located in Durham, NC.

Who invested in Chimerix?

Chimerix has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Chimerix?

Chimerix closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

chimerix.com

Chimerix

Chimerix is a North Carolina-based biopharmaceutical company that develops and commercializes antiviral therapies for the treatment of smallpox and cancer.

Business Model:

Revenue: $33.1M

Employees: 51-200

Geographic Data

Address: 2505 Meridian Parkway

City: Durham

State: NC

Zip: 27713

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$50M

Raised Total:

$325M

Social

Facebook

Twitter

Crunchbase

Metrics

54,575Website Global Rank

1,927,716Website Monthly Traffic

Twitter Followers

Description

Chimerix is a North Carolina-based biopharmaceutical company that develops and commercializes antiviral therapies for the treatment of smallpox and cancer.

Contact Phone:
+19198061074

Contact Email:

IPO Details

Chimerix went public on 4/12/2013 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/12/2013

IPO Valuation:
$342M

Ticker Symbol:
CMRX

IPO Price:
$14/share

Amount Raised:
$118M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
11/2022	Grant	1	$2M	Collaboratory Collaboratory
2/2011	Series F	8	$45M	Alta Partners Pappas Ventures New Leaf Venture Partners Sanderling Ventures Frazier Healthcare Partners Canaan Partners Asset Management Ventures (AMV) Morningside Group New Leaf Venture Partners Alta Partners Pappas Ventures New Leaf Venture Partners Sanderling Ventures Frazier Healthcare Partners Canaan Partners Asset Management Ventures (AMV) Morningside Group New Leaf Venture Partners
4/2013	IPO		$102.5M
8/2009	Series E		$16.1M	Canaan Partners Alta Partners Sanderling Ventures Asset Management Ventures
7/2002	Series A	1	$1M	Asset Management Company Asset Management Company
11/2004	Series C	3	$11M	Frazier Technology Ventures Sanderling Ventures Asset Management Ventures (AMV) Frazier Technology Ventures
7/2006	Series C	1	$1.5M	Asset Management Company
2/2011	Series F		$45M	New Leaf Venture Partners Pappas Ventures Morningside Group Canaan Partners Sanderling Ventures Alta Partners Asset Management Ventures Frazier Healthcare Ventures
9/2003	Grant	1	$36.1M	National Institutes of Health
2/2007	Series D	6	$23.1M	Canaan Partners Sanderling Ventures Frazier Healthcare Partners Asset Management Ventures (AMV) Asset Management Company Alta Partners Canaan Partners
9/2003	Series B	2	$3.1M	Sanderling Ventures Asset Management Company Sanderling Ventures Asset Management Company
8/2009	Series E	5	$16.1M	Asset Management Ventures (AMV) Alta Partners Sanderling Ventures Canaan Partners Asset Management Company Asset Management Ventures (AMV) Alta Partners
1/2021	Post-IPO Equity		$100M
2/2022	Post-IPO Debt		$50M
7/2019	Post-IPO Equity		$34.9M
5/2014	Post-IPO Equity		$119.4M

Acquisitions

Announced Date	Name	Price
1/2021	Oncoceutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details